Back to Search
Start Over
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results.
- Source :
- Clinical Lung Cancer; May2018, Vol. 19 Issue 3, p213-220.e4, 12p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15257304
- Volume :
- 19
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical Lung Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 129329356
- Full Text :
- https://doi.org/10.1016/j.cllc.2017.11.003